已收盘 08-01 16:00:00 美东时间
-0.050
-0.53%
今日重点评级关注:Craig-Hallum:维持DiaMedica Therapeutics"买入"评级,目标价从8美元升至11美元;花旗:维持Cogent Biosciences"买入"评级,目标价从15美元升至22美元
07-21 09:19
Wells Fargo analyst Gabe Hajde maintains Amcor (NYSE:AMCR) with a Overweight and raises the price target from $10 to $11.
07-19 03:20
Truist Securities analyst Michael Roxland maintains Amcor (NYSE:AMCR) with a Buy and lowers the price target from $12 to $11.
07-11 20:45
It hardly seems possible that we have already covered six months of 2025. Of co...
07-03 23:22
Redburn Atlantic:下调Adobe(ADBE)评级至"卖出",目标价从420美元降至280美元
07-03 11:01
Jefferies analyst Philip Ng initiates coverage on Amcor (NYSE:AMCR) with a Buy rating and announces Price Target of $12.
07-02 20:00
Analysts are intrested in these 5 stocks: ( ($BROS) ), ( ($EQIX) ), ( ($LEU) ),...
06-28 17:01
UBS analyst Nathan Reilly upgrades Amcor (NYSE:AMCR) from Neutral to Buy.
06-26 19:57
Innovative material saving enhances sustainability ZURICH, June 10, 2025 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solu...
06-10 22:09
(转自:纳指弹幕组) 原则:1)本公众号为私人所有, 与任何机构无关;2)本公众号仅归纳和转述英文外资研报, 不输出个人主观...
05-06 22:42